SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-24-002085
Filing Date
2024-01-11
Accepted
2024-01-11 16:43:36
Documents
11

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 266071
2 ex5-1.htm EX-5.1 31217
3 ex23-1.htm EX-23.1 3826
4 ex23-2.htm EX-23.2 4131
5 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 23318
6 forms-3_001.jpg GRAPHIC 4204
7 forms-3_002.jpg GRAPHIC 4213
8 ex5-1_001.jpg GRAPHIC 8992
9 ex5-1_002.jpg GRAPHIC 15665
10 ex5-1_003.jpg GRAPHIC 11199
11 ex5-1_004.jpg GRAPHIC 6517
  Complete submission text file 0001493152-24-002085.txt   400459
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276473 | Film No.: 24529659
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)